Last updated: March 8, 2026 (Week 11)
AI — The Cognitive Revolution
Tier 1: Foundation Model Labs
| Company | Status | Valuation | Why It Matters |
|---|
| OpenAI | Private, IPO expected 2026/27 | $730–840B | Core of the agent revolution. $110B funding round (Feb 2026). Amazon, NVIDIA, SoftBank as investors. GPT-5.4 with native computer use. |
| Anthropic | Private, IPO possible 2026/27 | $380B | $30B Series G (Feb 2026). Claude as enterprise standard. Pentagon supply chain risk classification paradoxically boosted public sympathy. |
| Google DeepMind | Part of Alphabet (GOOGL) | — | Gemini 2.0 family. Google Cloud AI infrastructure. Kairos Power nuclear deal. |
| Meta AI | Part of Meta (META) | — | Llama open-source models. Massive AI infrastructure investments. Oklo deal for nuclear power. Ordering millions of Vera Rubin GPUs. |
| DeepSeek | Private (China) | Undisclosed | V4 model (trillion-parameter, multimodal) imminent. Working with Huawei on chip independence. Proves China’s open-source AI is competitive. |
Tier 2: AI Infrastructure & Compute
| Company | Ticker | Why It Matters |
|---|
| NVIDIA | NVDA | $68B quarterly revenue (+73% YoY). Data Center $62B (+75%). Blackwell + Rubin: >$500B revenue pipeline. GTC 2026 on March 16–19. |
| CoreWeave | CRWV | AI cloud pure-play. $30–35B CapEx planned for 2026. +322% since IPO. Securities fraud class action pending. |
| Cerebras | IPO ~April 2026 | $23.1B valuation. Morgan Stanley as lead underwriter. Wafer-scale chip as NVIDIA alternative. |
| AMD | AMD | Alternative to NVIDIA for AI training. MI300 series. |
| Broadcom | AVGO | Custom AI chips for hyperscalers. |
Tier 3: Agent Economy & Applications
| Company | Status | Why It Matters |
|---|
| Coinbase | COIN | Agentic Wallets live since Feb 2026. >50M transactions. x402 protocol. Bridge between AI agents and crypto. |
| Kite | Token | First “AI Payment Blockchain.” Layer 1 for the autonomous economy. +140% in 90 days. |
| Perplexity AI | Private | AI search engine. CoreWeave deal for GB200 cluster. Inference-focused. |
Robotics — AI Gets Bodies
Humanoid Robots
| Company | Status | Why It Matters |
|---|
| Tesla (Optimus) | TSLA | Gen 3 reveal Q1 2026. Fremont factory converting from Model S/X to Optimus. Target: 1M units/year at maturity. |
| Figure AI | Private | $1.75B total funding. OpenAI partnership. Figure 02 at BMW plants for 11 months. Bezos as investor. |
| Unitree | Private (China) | $3B valuation. Humanoid robots under $20,000. Tencent-backed. >5,000 units delivered. Available in Spain. |
| XPeng (IRON) | XPEV | New factory in Guangzhou. Large-scale production by end 2026. China’s answer to Optimus. |
| Neura Robotics | Private (Germany) | €1B funding from Tether at €4B valuation. Europe’s most significant humanoid player. Crypto capital funds physical AI. |
| Agility | Private | Rebranded from “Agility Robotics” (March 2026). Digit robots at Toyota, Mercado Libre. “Labor redefinition platform.” |
| AI2 Robotics | Private | $144M Series B (Feb 2026). Allen Institute spin-off. |
| Boston Dynamics | Hyundai subsidiary (HYMTF) | Atlas (electric). CEO Robert Playter resigned. Atlas-DeepMind partnership. All 2026 deployments sold out. |
| Apptronik | Private | Mercedes-Benz partnership. Transitioning from lab to kitting/toting. |
Crypto — Machine Money
Protocols & Layer 1/2
| Asset | Ticker | Why It Matters |
|---|
| Bitcoin | BTC | Store of value. Institutional adoption via ETFs. ~$71,000 (March 8). US legislation: crypto as commodities. |
| Ethereum | ETH | Smart contract platform. ERC-4337 account abstraction for agent wallets. ~$2,050 (March 8). |
| Solana | SOL | Fastest L1. Growing DeFi ecosystem. Stablecoin volume exploding. |
| Arbitrum / Optimism | ARB / OP | Layer 2 for microtransactions. Essential for M2M payments. |
| Circle (USDC) | IPO expected | Stablecoin infrastructure. $27+ trillion transaction volume 2024. GENIUS Act regulation. |
AI × Crypto Convergence
| Project | Status | Why It Matters |
|---|
| Paradigm Fund IV | VC fund ($1.5B) | Explicit pivot from pure crypto VC to AI + Robotics + Crypto. First top-tier convergence fund. |
| a16z Crypto Fund V | $2B fund | Closing planned H1 2026. |
| Fetch.ai | FET | Agent network on blockchain. Machine-to-machine transactions. |
| Ocean Protocol | OCEAN | Decentralized data market for AI training. |
| Render Network | RNDR | Decentralized GPU compute for AI/3D. |
| Filecoin | FIL | Decentralized storage. AI data infrastructure. |
Regulation
| Topic | Status | Impact |
|---|
| US Market Structure Bill | Draft submitted | XRP, SOL, LTC, HBAR, DOGE, LINK as commodities. $75M fundraising exemption without SEC. |
| GENIUS Act (Stablecoins) | OCC rules proposed | Federal stablecoin regulation. Limits on yield. Published in Federal Register March 2. |
| EU MiCA | In effect | European crypto framework. Compliance overhead. |
| EU AI Act | High-risk provisions Aug 2, 2026 | 2nd draft Code of Practice published March 5. Five months to compliance deadline. |
Energy — The Invisible Bottleneck
Nuclear & SMR
| Company | Ticker | Why It Matters |
|---|
| NuScale Power | SMR | Only NRC-certified SMR design. DOE/ORNL AI partnership. $4B market cap, under pressure. |
| Oklo | OKLO | Sam Altman as chairman. Aurora micro-reactor at INL, target July 4, 2026. Meta deal. ~$10B valuation. |
| Kairos Power | Private | Google deal for nuclear power. Salt-cooled reactor. |
| Constellation Energy | CEG | Largest US nuclear operator. Microsoft Three Mile Island restart. |
| Cameco | CCJ | World’s largest publicly traded uranium producer. |
Brain-Computer Interfaces
| Company | Status | Why It Matters |
|---|
| Neuralink | Private ($9.7B) | 21 human patients. Blindsight roadmap revealed. Mass production 2026. Automated surgery. |
| Synchron | Private ($200M Series D) | Stentrode (minimally invasive). Apple and NVIDIA partnerships. 5-year implant experience documented. |
| Merge Labs | Private ($850M) | OpenAI-backed ($250M seed). Non-invasive BCIs. Bridging biological and artificial intelligence. |
| Paradromics | Private ($105M+) | Highest demonstrated information transfer rates (>200 bps). NIH and DARPA backed. |
| Science Corp. | Private ($230M Series C) | Founded by ex-Neuralink president. PRIMA retinal implant. Could be first commercial BCI. CE approval mid-2026. |
| NeuroXess | Private (China) | Patient controlled cursor <1 week after implant. China’s BCI push: public use in 3–5 years. |
Longevity & Biotech
| Company | Status | Why It Matters |
|---|
| Immorta Bio | Private | Doubled mouse lifespan by eliminating senescent cells. Senovax + Stem Cell Revivify. |
| Unity Biotechnology | UBX | Senolytic therapies. Clinical stage. |
| Altos Labs | Private | Bezos-backed. Cellular reprogramming. |
| Calico | Alphabet subsidiary | Longevity research. Deep pockets. |
| Juvenescence | Private | Phase 2 proof-of-concept trial 2026. Metabolic/fibrotic diseases. Ventures include Juvenomics. |
📋 About This Watchlist
This is a living document, updated every Friday as part of the Convergence Thesis weekly deep research. Companies are tracked across all six pillars of the thesis: AI, Robotics, Crypto, Energy, BCIs, and Longevity. Ticker links go to Yahoo Finance for real-time quotes.
New entries are added when they demonstrate relevance to the convergence of these domains. Want updates? Subscribe to the weekly newsletter →